# RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries

> **NCT01150500** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 65 (actual)

## Conditions studied

- Arterial Occlusive Diseases
- Myocardial Ischemia
- Cardiovascular Diseases
- Coronary Artery Disease

## Interventions

- **DEVICE:** MDT-4107 Zotarolimus-Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT01150500
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-10
- **Final completion:** 2016-06
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2017-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150500, "RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01150500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*